Standard Biotools is trading 6.44% up now at $0.69, with healthcare-sector strength appearing to support its rebound from several recent declines.
- XLV was reported up 1.29%, while trading activity reached approximately 2.01 million shares versus 1.26 million average volume.
- No new company-specific announcement dated August 20 or August 21 was identified; the latest company release was second-quarter results published August 5.